Simultaneous qualitative detection and differentiation of SARS-CoV-2 nucleocapsid antigen and/or influenza A and B nucleoprotein antigens directly from anterior nasal swab samples taken from individuals who are suspected of a viral respiratory infection consistent with COVID-19 by a healthcare provider, within the first six days of symptom onset. Emergency use of this test is limited to authorized laboratories.
Simplify the testing process - Easy operation and 1-button functionality may help reduce manual test processing errors
- Simple sample processing with color-coded tubes
Achieve fast, reliable results- Displays easy-to-read digital results for COVID-19 in 15 minutes: “CoV2: +” for positive, “CoV2: -” for negative
Provide workflow efficiency - Adapts easily to your workflow by offering 2 operational modes
- Walk away: Test device is inserted immediately into Analyzer, so staff can multi-task while sample incubates (15 minutes)
- Analyze now: Test device is inserted after incubation time is complete, allowing batches of samples to be tested (results in seconds)
Provide result traceability- Download and display Lot number, patient/specimen ID,
- Operator ID and test records with BD Veritor™ InfoScan module
- Offers result-printing capabilities via USB port
